Cite
2746. Effectiveness of Influenza Vaccine for Prevention of Influenza-associated Hospitalizations Among Immunocompromised Adults—2017–2018.
MLA
Silveira, Fernanda P., et al. “2746. Effectiveness of Influenza Vaccine for Prevention of Influenza-Associated Hospitalizations Among Immunocompromised Adults—2017–2018.” Open Forum Infectious Diseases, vol. 6, Oct. 2019, p. S967. EBSCOhost, https://doi.org/10.1093/ofid/ofz360.2423.
APA
Silveira, F. P., Hughes, K. L., Balasubramani, G. K., Middleton, D., Nowalk, M. P., Martin, E. T., Gaglani, M., Talbot, H. K., Ferdinands, J., & Zimmerman, R. (2019). 2746. Effectiveness of Influenza Vaccine for Prevention of Influenza-associated Hospitalizations Among Immunocompromised Adults—2017–2018. Open Forum Infectious Diseases, 6, S967. https://doi.org/10.1093/ofid/ofz360.2423
Chicago
Silveira, Fernanda P, Kailey L Hughes, G K Balasubramani, Donald Middleton, Mary Patricia Nowalk, Emily T Martin, Manjusha Gaglani, H Keipp Talbot, Jill Ferdinands, and Richard Zimmerman. 2019. “2746. Effectiveness of Influenza Vaccine for Prevention of Influenza-Associated Hospitalizations Among Immunocompromised Adults—2017–2018.” Open Forum Infectious Diseases 6 (October): S967. doi:10.1093/ofid/ofz360.2423.